维生素D补充对骨骼肌肉健康的影响:系统综述、荟萃分析与试验序贯分析
结果显示维生素D对总骨折、髋部骨折、跌倒及骨密度均无显著改善,高剂量与低剂量效果相似,提示缺乏使用维生素D维持骨骼肌肉健康的依据。
要点
- 维生素D补充不降低总骨折、髋部骨折或跌倒风险。
- 高剂量与低剂量维生素D对骨折和跌倒的效果相似。
核心结论
- 维生素D补充不能预防骨折或跌倒,对骨密度也无临床意义的影响。
- 高剂量与低剂量维生素D的效果无差异,缺乏使用维生素D维持骨骼肌肉健康的依据。
研究设计与样本
- 纳入成人(>18岁)随机对照试验,比较维生素D与未治疗对照、安慰剂或低剂量维生素D。
关键数值与推荐
- 髋部骨折在15%相对风险下,效果估计位于无益边界与劣效边界之间。
临床怎么用
- 临床指南应反映维生素D补充不改善骨骼肌肉健康的结论。
- 不建议使用维生素D补充剂来维持或改善骨骼肌肉健康。
局限性
- 检索截止2017年9月14日和2018年2月26日,后续研究未纳入。
- 仅纳入先前荟萃分析中的随机对照试验,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effects of vitamin D on fractures, falls, and bone mineral density are uncertain, particularly for high vitamin D doses. We aimed to determine the effect of vitamin D supplementation on fractures, falls, and bone density. METHODS: In this systematic review, random-effects meta-analysis, and trial sequential analysis, we used findings from literature searches in previously published meta-analyses. We updated these findings by searching PubMed, Embase, and Cochrane Central on Sept 14, 2017, and Feb 26, 2018, using the search term "vitamin D" and additional keywords, without any language restrictions. We assessed randomised controlled trials of adults (>18 years) that compared vitamin D with untreated controls, placebo, or lower-dose vitamin D supplements. Trials with multiple interventions (eg, co-administered calcium and vitamin D) were eligible if the study groups differed only by use of vitamin D. We excluded trials of hydroxylated vitamin D analogues. Eligible studies included outcome data for total or hip fractures, falls, or bone mineral density measured at the lumbar spine, total hip, femoral neck, total body, or forearm. We extracted data about participant characteristics, study design, interventions, outcomes, funding sources, and conflicts of interest. The co-primary endpoints were participants with at least one fracture, at least one hip fracture, or at least one fall; we compared data for fractures and falls using relative risks with an intention-to-treat analysis using all available data. The secondary endpoints were the percentage change in bone mineral density from baseline at lumbar spine, total hip, femoral neck, total body, and forearm. FINDINGS: We identified 81 randomised controlled trials (n=53 537 participants) that reported fracture (n=42), falls (n=37), or bone mineral density (n=41). In pooled analyses, vitamin D had no effect on total fracture (36 trials; n=44 790, relative risk 1·00, 95% CI 0·93-1·07), hip fracture (20 trials; n=36 655, 1·11, 0·97-1·26), or falls (37 trials; n=34 144, 0·97, 0·93-1·02). Results were similar in randomised controlled trials of high-dose versus low-dose vitamin D and in subgroup analyses of randomised controlled trials using doses greater than 800 IU per day. In pooled analyses, there were no clinically relevant between-group differences in bone mineral density at any site (range -0·16% to 0·76% over 1-5 years). For total fracture and falls, the effect estimate lay within the futility boundary for relative risks of 15%, 10%, 7·5%, and 5% (total fracture only), suggesting that vitamin D supplementation does not reduce fractures or falls by these amounts. For hip fracture, at a 15% relative risk, the effect estimate lay between the futility boundary and the inferior boundary, meaning there is reliable evidence that vitamin D supplementation does not reduce hip fractures by this amount, but uncertainty remains as to whether it might increase hip fractures. The effect estimate lay within the futility boundary at thresholds of 0·5% for total hip, forearm, and total body bone mineral density, and 1·0% for lumbar spine and femoral neck, providing reliable evidence that vitamin D does not alter these outcomes by these amounts. INTERPRETATION: Our findings suggest that vitamin D supplementation does not prevent fractures or falls, or have clinically meaningful effects on bone mineral density. There were no differences between the effects of higher and lower doses of vitamin D. There is little justification to use vitamin D supplements to maintain or improve musculoskeletal health. This conclusion should be reflected in clinical guidelines. FUNDING: Health Research Council of New Zealand.
引用
- Bolland MJ, Grey A, Avenell A, et al. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018. PMID: 30293909. doi:10.1016/S2213-8587(18)30265-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。